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Gastrointestinal stromal tumors (GISTs) are the most frequent mesenchymal tumors of the gastrointestinal tract with surgical
resection remaining the cornerstone of therapy. Pararectal lesions are considered to be technically difficult and pose in some
cases a challenge. We report, to the best of our knowledge, the first robotic-assisted pararectal GIST excision. A 43-year-old
man was referred to our center with pararectal GIST recurrence, despite treatment with targeted therapy. Eleven years ago, he
underwent extensive abdominal surgery including cystoprostatectomy with ileal neobladder diversion due to GIST resection in the
rectoprostatic space. Robot-assisted surgical resection was successfully performed without the need for temporary colostomy. The
postoperative course of the patient was uneventful, and the pathology report confirmed a GIST recurrence with negative surgical
margins and pelvic lymph nodes free of any tumor. Robotic-assisted pelvic surgery can be extended to incorporate excision of
pararectal GISTs, as a safe, less invasive surgical alternative with promising oncological results and minimal injury to adjacent
structures.
1. Introduction
Gastrointestinal stromal tumors (GISTs) are the most fre-
quent mesenchymal tumors of the gastrointestinal tract with
an incidence of 3300–4350 cases per year in the United States.
Themost common sites of occurrence are the stomach (60%)
and the small intestine (30%), while about 5% originate in the
colon and rectum. Growing knowledge of the pathogenesis of
the disease and targetedmolecular therapies have revolution-
ized the treatment of rectal GISTs, though surgical excision
still remains the mainstay of therapy [1, 2].
Rectal lesions are considered to be technically difficult
and pose in some cases a challenge to the surgeon due to
the confined space of the pelvis combined with the inherent
capability of the tumor to adhere to adjacent structures or
even the pelvic floor [3, 4].However, advantages of the robotic
platform, such as the magnified visual field accompanied by
the wristed instrumentation, can facilitate radical resection
with minim tissue trauma. We report to the best of our
knowledge, the first robotic-assisted pararectal GIST excision
in a patient with previous extensive abdominal surgery.
2. Case Report
A 43-year-old man was referred to our institution with a
pararectal recurrence of aGIST. In 2001, he underwent an ini-
tial resection of a GIST localized in the rectoprostatic space.
This procedure resulted in an open partial rectal resection
with temporary colostomy and a cystoprostatectomy with
creation of an ileal neobladder. Since 2009, he was followed
for a pararectal lesion suspicious for recurrence, which was
confirmed with biopsies. Despite the initial treatment with
imatinib mesylate, progressive tumor growth occurred. The
patient placed a high priority on his quality of life and was
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reluctant to any open procedure that would likely end up in
a temporary diverting colostomy. Therefore, the patient was
planned for robot-assisted tumor enucleation in an attempt
to minimize collateral damage.
The patient was bowel prepped the day before surgery.
After endotracheal intubation, the patient was adequately
padded, draped, and placed in a 30-degree trendelenburg
position with the legs apart. Broad-spectrum antibiotics were
administered and a bladder catheter was placed. Due to the
previous cystoprostatectomy procedure with ileal neobladder
diversion, adhesions were expected; thus, the camera port
was placed with open technique and a thorough inspection
of the abdomen was performed.Three robotic and two assist-
ing trocars were inserted under vision, in a configuration
similar to that used in robotic-assisted radical prostatectomy
[5]. Anatomical orientation in an abdomen with previous
extensive surgery was of paramount importance with the 3D
robotic vision having evident advantages. Thorough adhesi-
olysis was performed and retrograde filling of the neobladder
with normal saline aided in identifying its borders. Meticu-
lous dissection was applied along the sigmoid, detaching it
from the left lateral abdominal wall in an effort to keep it as
a landmark and enter the true pelvis in a safe plane of dis-
section. MRI imaging through TILEPro (Intuitive Surgical,
Inc.) technology was used to confirm the level of the tumor
in the pelvis throughout the whole procedure (Figure 1). The
fourth robotic instrument was used for traction, while coun-
tertraction was applied from the assistant with laparoscopic
instruments. The tumor was located in the left lateral wall
of the rectum and was dissected free under direct vision
with safe margins from THE surrounding structures and the
mucosa of the rectum avoiding any iatrogenic penetration of
the pseudocapsule (Figures 2(a) and 2(b)). At the same time,
care was taken not to further injure the rectal wall and enter
the rectal lumen. Retrograde insufflation of the rectum with
air, while filling the pelvis with water, confirmed no rectal
leak. Consequently, the rectal defect was sutured with 3-0
VICRYL (Ethicon Inc.,) in a two-layer fashion (Figure 2(c)).
Suspiciously, enlarged lymph nodes that were noted along the
left obturator fossa and hypogastric artery were resected for
pathology (Figure 2(d)). No temporary diverting colostomy
was offered. After confirming hemostasis, a drain was placed
in the pelvis and a laparoscopic entrapment bag was used to
retrieve the specimen.
Console time was 130min and estimated blood loss was
200 cc. No intraoperative complications were encountered.
Convalescence was uneventful with the patient passing flatus
on day one. Clear liquids were consumed on the first postop-
erative day, which was switched to a fiber-free diet for 7 days
before starting a normal diet. The patient was discharged the
third day postoperatively.The histopathology report revealed
a GIST, with a maximum diameter of 3.3 cm consisting of a
proliferative cell-rich component with spindle cells and areas
of hemorrhage and necrosis. The other component was cell
poor with mucoid degeneration and some vital tumor cells.
The tumor cells were CD117- and CD34-positive.The surgical
margins were negative and the lymph nodes were free of
tumor as well.
Figure 1: Pelvic MRI of the patient. The arrow demonstrates the
pararectal GIST.
3. Discussion
GISTs are mesenchymal tumors that arise from the intestinal
cells of Cajal. These cells are part of the myenteric plexus
of the gut wall and regulate the autonomic nerve system.
They function as a pacemaker controlling the intestinal
motility. On their cell surface, they express CD117 or c-KIT,
which is a transmembrane receptor protein with tyrosine
kinase function that regulates proliferation, differentiation,
cell adhesion, and apoptosis. GISTs occur due to mutation on
the c-KIT protein that leads to gain of function resulting in
continuous activation of the protein and subsequent unreg-
ulated proliferation. Imatinib mesylate, a tyrosine kinase
inhibitor, binds to the specific domain of the receptor causing
regression of the CD117 positive GISTs [1, 2, 6].
The National Institute of Health Workshop has subdi-
vided the GISTs based on the risk of malignant behavior.
A cut-off point of 5 mitoses per 50 HPF is regarded as the
upper limit for benign behavior, especially in gastric GISTs
[7]. As far as the anorectal GISTs are concerned, this has been
addressed in a study by Miettinen et al., where 144 cases of
anorectal GISTs were prospectively analyzed. Tumors in the
very low risk group (<2 cm of size and <5 mitoses/HPF) with
low rate of recurrence and indolent behavior were considered
suitable for local resection, while tumors with malignant
behavior (>5 cm of size or >5mitoses/50 HPF) had high rates
of recurrence and metastasis [8].
Although, targeted therapy has given new perspective in
the treatment of the disease, especially in the neoadjuvant and
adjuvant setting, surgery remains the cornerstone of therapy
for patients with primary GIST when being technically fea-
sible with limited morbidity. Negative surgical margins and
preventing intraoperative rupture of the tumor are of utmost
importance, while lymph node dissection is not necessary,
except in patients where suspicious nodes are encountered
such as in our case. With regard to anorectal GISTs, local
excision may be sufficient with a minimum risk of morbidity
and preservation of the anal sphincter, while in some cases
more extensive surgery is unavoidable [1, 6].
Small series of laparoscopic resection of gastric GISTs
have been reported in the literature with good oncological
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Figure 2: (a)The tumor is identified at the left lateral wall of the rectum. (b)The GIST is dissected free under direct vision with safe margins.
(c) Suturing the rectal wall in a two-layer fashion with the mucosa of the rectum intact. (d) Resection of suspicious pelvic lymph nodes. G:
GIST, R: rectum, M: mucosa of the rectum, and L: pelvis lymph node.
results [9]. On the other hand, data on laparoscopic resection
of rectal GISTs is sparse with few case reports published
[3, 4, 10]. A common remark in these reports is the substantial
advantage of the magnified visual field, which can potentially
benefit the patient by less extensive resections. Recently,
robot-assisted surgery has been implemented in the past for
the resection of gastric GISTs. Most authors conclude that
the wristed instrumentation combined with the enhanced
vision aids in performing an oncologically safe resection
while preserving adjacent tissue, even in large tumors or
tumors with a difficult location [11–13]. In this case, a robotic
approach was decided not only for the potential advantages
of a less invasive procedure, but also for the induction of
minimal collateral injury during access to the deep pelvis
having always in mind the safety of the neobladder and
its vasculature. The freedom of motion of the robotic arms
is appreciated especially during suturing in difficult angles
where ensuring reapproximation of the defect is important,
thus avoiding a temporary colostomy.
4. Conclusion
Robotic surgery with the wristed instrumentation and three-
dimensional vision has proven advantages compared to
conventional laparoscopy, especially in confined spaces such
as the pelvis. We report to the best of our knowledge the first
robotic-assisted pararectal GIST excision. As demonstrated
in this case, the indications for robotic-assisted pelvic surgery
can be extended to incorporate excision of rectal GISTs, as a
safe andminimal invasive surgical alternative with promising
oncological results. In experienced hands, previous extended
abdominal operations should not be considered an absolute
contraindication for robotic surgery.
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